During the past decade, GASTRO JeKa, s.r.o. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "GASTRO JeKa, s.r.o." #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "GASTRO JeKa, s.r.o." are "Ulcerative Colitis" (5 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "GASTRO JeKa, s.r.o." in a lesser frequency.

Most popular intervention types in "GASTRO JeKa, s.r.o." are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Etrasimod" (4 trials), "Placebo" (4 trials) and "RPC1063" (2 trials). Other intervention names were less common.

The vast majority of trials in "GASTRO JeKa, s.r.o." are 6 trials for "All" genders.

Currently, there are NaN active trials in "GASTRO JeKa, s.r.o.". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in GASTRO JeKa, s.r.o., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in GASTRO JeKa, s.r.o., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".